NYLIM
NVAX icon

New York Life Investment Management’s Novavax NVAX Stock Holding History

New York Life Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,616
Closed -$101K – 1337
2023
Q1 		$101K Buy
14,616
+2,496
+21% +$23K ﹤0.01% 1196
2022
Q4 		$125K Buy
+12,120
New +$214K ﹤0.01% 1187
2022
Q3 		– Sell
-4,206
Closed -$217K – 1243
2022
Q2 		$217K Buy
+4,206
New +$218K ﹤0.01% 1219

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New York Life Investment Management's NVAX Position: Q2 2023 in Review

New York Life Investment Management sold out of Novavax (NVAX) in Q2 2023, closing a stake of 14,616 shares — an estimated $101K sold.

New York Life Investment Management first reported a position in NVAX in Q2 2022 and held it in 3 quarters. The position peaked at $217K in Q2 2022. 216 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

  • New York Life Investment Management reported no remaining Novavax position as of Q2 2023 after selling out during the quarter.
  • New York Life Investment Management sold 14,616 Novavax shares in Q2 2023, an estimated $101K.
  • New York Life Investment Management first reported a position in Novavax in Q2 2022 and held it in 3 quarters.
  • New York Life Investment Management's Novavax position peaked at $217K in Q2 2022.
  • 216 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on New York Life Investment Management's 13F filing for Q2 2023, filed 7 Aug 2023.